Assessment of insulin resistance in the idiopathic hirsutism

Gynecologic and Obstetric Investigation

Volumn 63, Issue 3, 2007, Pages 126-131

  Sarac, Fulden ^a   Saygili, Fusun ^a   Özgen, Gökhan ^a   Tuzun, Mehmet ^a   Yilmaz, Candeger ^a   Kabalak, Taylan ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Hyperinsulinemic euglycemic clamp; Idiopathic hirsutism; Insulin resistance

Indexed keywords

CORTICOTROPIN; FOLLITROPIN; GLUCOSE; HYDROXYPROGESTERONE; INSULIN; LUTEINIZING HORMONE; PROLACTIN; TESTOSTERONE;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HIRSUTISM; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; OBESITY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

17-ALPHA-HYDROXYPROGESTERONE; ADRENAL CORTEX HORMONES; ADRENOCORTICOTROPIC HORMONE; ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DEHYDROEPIANDROSTERONE SULFATE; ESTROGENS; FEMALE; FOLLICLE STIMULATING HORMONE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HIRSUTISM; HUMANS; INSULIN; INSULIN RESISTANCE; LUTEINIZING HORMONE; PROGESTERONE; PROLACTIN; TESTOSTERONE; THYROID HORMONES;

EID: 34047176997     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096434     Document Type: Article

References (40)

1. Moran C, Tapia MC, Hernandez E, Vazquez G, Garcia-Hernandez E, Bermudez JA: Etiological review of hirsutism in 250 patients. Arch Med Res 1994;25:311-314.
2. Unluhizarci K, Karababa Y, Bayram F, Kelestimur F: The investigation of insulin resistance in patients with idiopathic hirsutism. J Clin Endocrinol Metab 2004;89:2741-2744.
3. Barth JH: Investigations in the assessment and management of patients with hirsutism. Curr Opin Obstet Gynecol 1997;9:187-192.
4. Vrbikova J, Bendlova B, Hill M, Vankova M, Vondra K, Starka L: Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome. Diabetes Care 2002;25:1217-1222.
5. Jialal I, Naiker P, Reddi K, Moodley J, Joubert SM: Evidence for insulin resistance in non-obese patients with polycystic ovarian disease. J Clin Endocrinol Metab 1987;64:1066-1069.
6. Toprak S, Yonem A, Cakir B, Guler S, Azal O, Ozata M: Insulin resistance in non-obese patients with polycystic ovary syndrome. Horm Res 2001;55:65-70.
7. Conway GS: Hyperinsulinaemia and polycystic ovary syndrome. Hum Fertil 2000;3:93-95.
8. Franks S, Gilling-Smith C, Watson H, Willis D: Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am 1999;28:361-378.
9. Burghen GA, Givens JR, Kitabchi AE: Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. Clin Endocrinol Metab 1980;50:113-116.
10. Pugeat M, Ducluzeau PH, Mallion-Donadieu M: Association of insulin resistance with hyperandrogenia in women. Horm Res 2000;54:322-326.
11. Unluhizarci K, Kelestimur F, Bayram F: The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome. Clin Endocrinol 1999;51:231-236.
12. Glintborg D, Henriksen JE, Andersen M, Hagen C, Hangaard J, Rasmussen PE, Schousboe K, Hermann AP: Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis. Fertil Steril 2004;82:1570-1579.
13. Budec M, Pjevic M: The insulin response to oral glucose, concentrations of total cholesterol, triglycerides and uric acid in women with idiopathic hirsutism. Exp Clin Endocrinol 1989;94:300-304.
14. Paoletti AM, Cagnacci A, Orru M, Ajossa S, Guerriero S, Melis GB: Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism. Fertil Steril 1999;72:448-453.
15. Ferriman D, Gallwey JD: Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440.
16. De Fronzo RA, Tobin JD, Anders R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;6:214-223.
17. Smith S, Ravnikar VA, Barbieri R: Androgen and insulin response to an oral glucose challenge in hyperandrogenic women. Fertil Steril 1987;48:72-77.
18. Dunaif A, Sorbara L, Delson R: Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women. Diabetes 1993;42:1462-1468.
19. Shoupe D, Kumar DD, Lobo RA: Insulin resistance in polycystic ovary syndrome. Am J Obstet Gynecol 1983;147:588-592.
20. Fox JH, Licholai T, Green G, Dunaif A: Differential effects of oral glucose-mediated versus intravenous hyperinsulinemia on circulating androgen levels in women. Fertil Steril 1993;60:994-1000.
21. Elkind-Hirsch KE, Valdes CT, McConnell TG, Malinak LR: Androgen responses to acutely increased endogenous insulin levels in hyperandrogenic and normal cycling women. Fertil Steril 1991;55:486-491.
22. Barbieri RL: Insulin stimulates androgen accumulation in incubations of minced porcine theca. Gynecol Obstet Invest 1994;37:265-269.
23. Nestler JE: Insulin regulation of human ovarian androgens. Hum Reprod 1997;12:53-62.
24. Stuart CA, Prince MJ, Peters EJ, Meyer WJ: Hyperinsulinemia and hyperandrogenemia: in vivo androgen response to insulin infusion. Obstet Gynecol 1987;69:921-925.
25. Stuart CA, Nagamani M: Insulin infusion acutely augments ovarian androgen production in normal women. J Clin Endocrinol Metab 1990;71:1653-1657.
26. Micic D, Popovic V, Nesovic M, Sumarac M, Dragasevic M, Kendereski A, Markovic D, Djordjevic P, Manojlovic D, Micic J: Androgen levels during sequential insulin euglycemic clamp studies in patients with polycystic ovary disease. J Steroid Biochem 1988;31:995-999.
27. Nestler JE, Usiskin KS, Barlascini CO, Welty DF, Clore JN, Blackard WG: Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms. J Clin Endocrinol Metab 1989;69:1040-1046.
28. Nestler J, Clore JN, Strauss JF, Blackard WG: The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. Clin Endocrinol Metab 1987;64:180-184.
29. Falcone T, Finegood D, Fantos IG, Morris D: Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women. J Clin Endocrinol Metab 1990;71:1653-1657.
30. Lavallee B, Provost PR, Kahwash Z, Nestler JE, Belanger A: Effect of insulin on serum levels of dehydroepiandrosterone metabolites in men. Clin Endocrinol (Oxf) 1997;46:93-100.
31. Diamond MP, Grainger DA, Laudano AJ, Starick-Zych K, DeFronzo RA: Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women. J Clin Endocrinol Metab 1991;72:883-887.
32. Yamaguchi Y, Tanaka S, Yamakawa T, Kimura M, Ukawa K, Yamada Y, Ishihara M, Sekihara H: Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia. Clin Endocrinol 1998;49:377.
33. Stuart CA, Nagamani M: Insulin infusion acutely augments ovarian androgen production in normal women. J Clin Endocrinol Metab 1990;71:1653-1657.
34. Micic D, Popovic V, Nesovic M, Sumarac M, Dragasevic M, Kendereski A, Markovic D, Djordjevic P, Manojlovic D, Micic JN: Androgen levels during sequential insulin euglycemic clamp studies in patients with polycystic ovary disease. J Steroid Biochem 1988;31:995-999.
35. Schultes R, Kern W, Bong W, Wellhoener P, Kerner J, Born J, Fehm H, Peters A: Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans. J Clin Endocrinol Metab 1999;84:3041-3046.
36. Anttila L, Koskinen P, Jaatinen TA, Erkkola R, Irjala K, Ruutiainen K: Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease. Hum Reprod 1993;8:1179-1183.
37. Fruehwald-Schultes B, Kern W, Born J, Fehm HL, Peters A: Hyperinsulinemia causes activation of the hypothalamus-pituitary-adrenal axis in humans. Int J Obes Relat Metab Disord 2001;25:38-40.
38. Fruehwald-Schultes B, Kern W, Bong W, Wellhoener P, Kerner W, Born J, Fehm HL, Peters A: Supraphysiological hyperinsulinemia acutely increases hypothalamic pituitary adrenal secretory activity in humans. J Clin Endocrinol Metab 1999;84:3041-3046.
39. Frizzell RT, Hendrick GK, Biggers DW, Lacy DB, Donhue DP, Green DR, Carr RK, Williams PE, Stevenson RW, Cherrington AD: Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continous insulin infusion in conscious dogs. Diabetes 1988;37:749-759.
40. Peiris AN, Aiman EJ, Drucker WD, Kissebah AH: The relative contributions of hepatic and peripheral tissues to insulin resistance in hyperandrogenic women. J Clin Endocrinol Metab 1989;68:715-720.